Trial
NCT00123578
GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Substance-Related Disorders
Intervention
Lorazepam
Why stopped
Unable to recruit adaquate number of GHB dependent subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-12